Cargando…

Role of ASXL1 mutation in impaired hematopoiesis and cellular senescence

Detalles Bibliográficos
Autores principales:	Uni, Masahiro, Kurokawa, Mineo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6305153/ https://www.ncbi.nlm.nih.gov/pubmed/30627322 http://dx.doi.org/10.18632/oncotarget.26423

Ejemplares similares

Expression of mutant Asxl1 perturbs hematopoiesis and promotes susceptibility to leukemic transformation
por: Nagase, Reina, et al.
Publicado: (2018)

Experimental ASXL1 ‐Mediated Clonal Hematopoiesis Promotes Inflammation and Accelerates Heart Failure
por: Min, Kyung‐Duk, et al.
Publicado: (2022)

Tumor-derived neomorphic mutations in ASXL1 impairs the BAP1-ASXL1-FOXK1/K2 transcription network
por: Xia, Yu-Kun, et al.
Publicado: (2020)

ASXL2 regulates hematopoiesis in mice and its deficiency promotes myeloid expansion
por: Madan, Vikas, et al.
Publicado: (2018)

ASXL1 as a critical regulator of epigenetic marks and therapeutic potential of mutated cells
por: Inoue, Daichi, et al.
Publicado: (2018)

ASXL1 interacts with the cohesin complex to maintain chromatid separation and gene expression for normal hematopoiesis
por: Li, Zhaomin, et al.
Publicado: (2017)

Asxl1 deficiency in embryonic fibroblasts leads to cellular senescence via impairment of the AKT-E2F pathway and Ezh2 inactivation
por: Youn, Hye Sook, et al.
Publicado: (2017)

Cancer-associated ASXL1 mutations may act as gain-of-function mutations of the ASXL1–BAP1 complex
por: Balasubramani, Anand, et al.
Publicado: (2015)

Pathological ASXL1 Mutations and Protein Variants Impair Neural Crest Development
por: Matheus, Friederike, et al.
Publicado: (2019)

ASXL1/2 mutations and myeloid malignancies
por: Medina, Edward A., et al.
Publicado: (2022)

“ASXL1”-erating inflammation and bone marrow fibrosis in myeloproliferative neoplasms
por: Gleitz, Hélène F.E., et al.
Publicado: (2022)

ASXL1 mutations in Chinese patients with essential thrombocythemia
por: Nie, Yan-Bo, et al.
Publicado: (2018)

ASXL1 plays an important role in erythropoiesis
por: Shi, Hui, et al.
Publicado: (2016)

SETBP1 Mutations Drive Leukemic Transformation in ASXL1-Mutated MDS
por: Inoue, Daichi, et al.
Publicado: (2014)

RUNX1 mutations promote leukemogenesis of myeloid malignancies in ASXL1-mutated leukemia
por: Bera, Rabindranath, et al.
Publicado: (2019)

Asxl1 C-terminal mutation perturbs neutrophil differentiation in zebrafish
por: Fang, Xiao, et al.
Publicado: (2021)

Tracking the dynamics of cellular senescence
por: Heckenbach, Indra, et al.
Publicado: (2023)

Prognostic impact of ASXL1 mutations in chronic phase chronic myeloid leukemia
por: Bidikian, Aram, et al.
Publicado: (2022)

Cellular Senescence in Physiological and Pathological Processes
por: Finicelli, Mauro, et al.
Publicado: (2022)

Cellular senescence and lung cancer prognosis
por: Asaithamby, Aroumougame, et al.
Publicado: (2022)

Cellular senescence is a potential severity factor for COVID-19: Suitable targets required to eliminate cellular senescence
por: Mohiuddin, Md, et al.
Publicado: (2021)

Time Trends in Disseminated Intravascular Coagulation in Japan
por: Kurokawa, Mineo
Publicado: (2020)

Examining the neurodevelopmental and motor phenotypes of Bohring-Opitz syndrome (ASXL1) and Bainbridge-Ropers syndrome (ASXL3)
por: Ayoub, Maya C., et al.
Publicado: (2023)

Novel mutation in the ASXL3 gene in a Chinese boy with microcephaly and speech impairment: A case report
por: Li, Jin-Rong, et al.
Publicado: (2020)

Chipping in on clonal hematopoiesis
por: Gillis, Nancy K., et al.
Publicado: (2017)

Evolution of clonal hematopoiesis
por: van Zeventer, Isabelle A., et al.
Publicado: (2023)

The distinct biological implications of Asxl1 mutation and its roles in leukemogenesis revealed by a knock-in mouse model
por: Hsu, Yueh-Chwen, et al.
Publicado: (2017)

Acute myeloid leukemia in a father and son with a germline mutation of ASXL1
por: Seiter, Karen, et al.
Publicado: (2018)

Poor Prognostic Implication of ASXL1 Mutations in Korean Patients With Chronic Myelomonocytic Leukemia
por: Kim, Hyun-Young, et al.
Publicado: (2018)

Mutations in ASXL1 are associated with poor prognosis across the spectrum of malignant myeloid diseases
por: Gelsi-Boyer, Véronique, et al.
Publicado: (2012)

Prognostic interaction between ASXL1 and TET2 mutations in chronic myelomonocytic leukemia
por: Patnaik, M M, et al.
Publicado: (2016)

ASXL1 mutations are associated with distinct epigenomic alterations that lead to sensitivity to venetoclax and azacytidine
por: Rahmani, Nora E., et al.
Publicado: (2021)

Risk factors affect accurate prognosis in ASXL1-mutated acute myeloid leukemia
por: Fan, Yi, et al.
Publicado: (2021)

P985: THE ALLELIC RATIO OF DRIVER AND ASXL1 MUTATIONS IS PROGNOSTICALLY RELEVANT IN PMF
por: Coltro, G., et al.
Publicado: (2022)

A reappraisal of ASXL1 mutation sites and the cohesin-binding motif in myeloid disease
por: Johnson, Steven M., et al.
Publicado: (2023)

Cellular Senescence and Inflammaging in Age-Related Diseases
por: Olivieri, Fabiola, et al.
Publicado: (2018)

Trithorax group genes in hematopoiesis
por: Chase, Jennifer, et al.
Publicado: (2015)

Targeting mitochondria to stimulate hematopoiesis
por: Girotra, Mukul, et al.
Publicado: (2020)

Role of ASXL1 and TP53 mutations in the molecular classification and prognosis of acute myeloid leukemias with myelodysplasia-related changes
por: Devillier, Raynier, et al.
Publicado: (2015)

Underlying Disease and Clinical Phenotypes of Disseminated Intravascular Coagulation
por: Matsuda, Kensuke, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_h7guogetr868bvapglss5ltuk2